Brain Tumor Pathology

Papers
(The TQCC of Brain Tumor Pathology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report43
Primary papillary epithelial tumor of the sella: a case report of an emerging tumor type21
MAPK pathway alterations in polymorphous low-grade neuroepithelial tumor of the young: diagnostic considerations18
Novel case of ependymoma-like tumor with mesenchymal differentiation harboring ZFTA::RELA fusion in an adult14
PBRM1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma—a case report14
Clinical implications of molecular analysis in diffuse glioma stratification13
Loss of H3K27me3 in WHO grade 3 meningioma13
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu12
Molecular subtyping of ependymoma and prognostic impact of Ki-6712
Utility of real-time polymerase chain reaction for the assessment of CDKN2A homozygous deletion in adult-type IDH-mutant astrocytoma11
Prognostic significance of TERT promoter mutations in adult-type diffuse gliomas11
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas10
Aggressive nonfunctioning pituitary neuroendocrine tumors10
Insights in primary central nervous system lymphoma: a role for glymphatics?9
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment9
Preface for Brain Tumor Pathology vol.41 issue 28
Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors8
Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report8
Unique pathological findings of astroblastoma with MN1 alteration in a patient with late recurrence8
Touch imprint cytology is useful for the intraoperative pathological diagnosis of PitNETs’ surgical margins7
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment7
Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes7
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma7
Timing of H3K27me3 loss in secondary anaplastic meningiomas6
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas6
Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma6
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the T6
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement6
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas6
0.035713911056519